WVE insider buying – Wave Life Sciences Ltd.
8 insider purchases since 2016 worth $166.7M by 5 different insiders. Last 12 months: 2 purchases, $82.6M. Most recent filing: 2026-03-30.
Same time range as the chart above - each mark sits under the week of the trade. Circles = purchases (height = price paid, size = amount), red triangles = open-market sales of $50k+. Prices as reported, not adjusted for later stock splits. 2 older purchases (before the 5-year window) are listed in the table below.
Purchases are open-market buys (SEC Form 4, code "P") - insiders paying with their own money. Sales are open-market sales (code "S") of $50,000 or more; many sales are pre-planned (Rule 10b5-1) or made for taxes and diversification. Each row links to the original filing.
Bought, sold, still holding?
| Insider | Bought | First / last buy | Sold since 2016 | Holds now* | Status |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. Director | $74.5M 3× · 9,459,052 sh | 2017-11-13 2026-03-26 | – | 23,157,567 shares as of 2026-03-30 | Holds - never sold |
| GSK plc 10% Owner | $66.8M 3× · 7,561,930 sh | 2023-12-07 2025-12-11 | – | 18,245,691 shares as of 2025-12-15 | Holds - never sold |
| RA Capital Healthcare Fund LP Director | $20.4M 1× · 9,480,052 sh | 2022-06-16 2022-06-16 | – | 28,815 shares as of 2025-08-13 | Holds - never sold |
| Kolchinsky Peter Director | $5.0M 1× · 1,000,000 sh | 2023-12-11 2023-12-11 | – | 19,202,009 shares as of 2023-12-13 | Holds - never sold |
* Shares held after the insider's most recent SEC filing for this company (all share classes, direct and indirect). If an insider stops filing, later changes are not known.
Insider buying and selling by year
| Year | Purchases | Bought | Buyers | Sales | Sold |
|---|---|---|---|---|---|
| 2026 | 1 | $54.6M | 1 | 4 | $857,920 |
| 2025 | 1 | $27.9M | 1 | 16 | $19.6M |
| 2024 | 2 | $38.8M | 1 | 8 | $6.8M |
| 2023 | 1 | $5.0M | 1 | 2 | $294,820 |
| 2022 | 1 | $20.4M | 1 | 2 | $134,530 |
| 2021 | 0 | – | – | 1 | $118,437 |
| 2020 | 0 | – | – | 4 | $3.4M |
| 2019 | 1 | $10.0M | 1 | 9 | $4.3M |
| 2018 | 0 | – | – | 13 | $10.9M |
| 2017 | 1 | $9.9M | 1 | 4 | $11.5M |
| 2016 | 0 | – | – | 1 | $868,400 |
Insider purchases
| Filed | Insider | Role | Shares | Avg price | Value | Holdings | Filing |
|---|---|---|---|---|---|---|---|
| 2026-03-30 | RA CAPITAL MANAGEMENT, L.P. | Director | 8,772,496 | $6.23 | $54.6M | +48.2% | SEC |
| 2025-12-15 | GSK plc | 10% Owner | 1,470,000 | $19.00 | $27.9M | +8.8% | SEC |
| 2024-10-01 | GSK plc | 10% Owner | 2,791,930 | $8.00 | $22.3M | +20.0% | SEC |
| 2024-01-30 | GSK plc | 10% Owner | 3,300,000 | $5.00 | $16.5M | +30.9% | SEC |
| 2023-12-13 | Kolchinsky Peter | Director | 1,000,000 | $5.00 | $5.0M | +5.5% | SEC |
| 2022-06-21 | RA Capital Healthcare Fund LP | Director | 9,480,052 | $2.15 | $20.4M | +122.8% | SEC |
| 2019-01-28 | RA CAPITAL MANAGEMENT, LLC | Director | 263,158 | $38.00 | $10.0M | +3.5% | SEC |
| 2017-11-15 | RA CAPITAL MANAGEMENT, LLC | Director | 423,398 | $23.34 | $9.9M | +6.0% | SEC |
Insider sales
| Filed | Insider | Role | Shares | Avg price | Value | Type | Filing |
|---|---|---|---|---|---|---|---|
| 2026-08-13 | Rawcliffe Adrian | Director | 12,700 | $5.29 | $67,183 | Sale | SEC |
| 2026-02-27 | Francis Chris | Officer | 33,194 | $15.05 | $499,521 | Sale | SEC |
| 2026-02-11 | BOLNO PAUL | CEO | 10,480 | $13.45 | $140,956 | Sale | SEC |
| 2026-01-06 | Francis Chris | Officer | 9,375 | $16.03 | $150,260 | Sale | SEC |
| 2025-12-10 | Wagner Heidi L | Director | 14,000 | $13.50 | $189,000 | Sale | SEC |
| 2025-12-10 | Verdine Gregory L. | Director | 20,000 | $13.47 | $269,461 | Sale | SEC |
| 2025-12-10 | Tan Aik Na | Director | 134,218 | $13.58 | $1.8M | Sale | SEC |
| 2025-12-10 | Rawcliffe Adrian | Director | 42,000 | $15.00 | $630,000 | Sale | SEC |
| 2025-12-10 | Moran Kyle | CFO | 260,036 | $15.78 | $4.1M | Sale | SEC |
| 2025-12-10 | HENRY CHRISTIAN O | Director | 93,445 | $14.65 | $1.4M | Sale | SEC |
| 2025-12-10 | Francis Chris | Officer | 441,031 | $14.58 | $6.4M | Sale | SEC |
| 2025-12-10 | CORRIGAN MARK | Director | 16,115 | $13.49 | $217,330 | Sale | SEC |
| 2025-11-14 | Rawcliffe Adrian | Director | 16,115 | $6.79 | $109,421 | Sale | SEC |
| 2025-08-26 | Verdine Gregory L. | Director | 10,000 | $10.00 | $100,000 | Sale | SEC |
| 2025-08-26 | BOLNO PAUL | CEO | 217,351 | $10.10 | $2.2M | Sale | SEC |
Showing the latest 15 of 64 sales of $50,000+ since 2016.
Compiled automatically from public SEC filings. Not investment advice. Get every new insider purchase in the daily report.
Get every new insider purchase the day it's filed
Daily report with all SEC insider buys, cluster buys, company events and the crypto money-flow radar.
Get started free